Hologic in the past 6 months have paid $10.4M USD to LDX which is more than our market cap. They clearly like our IP (40+ approved patents) and have been dealing with Lumos for several years now.
It would be foolish for Hologic to negotiate another $10M+ USD IP deal for another disease. They would be smarter to propose a takeover at 7c+.
We would be just a rounding error for Hologic who have a $25B market cap, plus the weak AUD makes it an attractive idea.
As for the lack of director buying, they would be in a blackout period if anything material is pending.
I'm very interested to see how this company trades during the course of the year.
Hologic in the past 6 months have paid $10.4M USD to LDX which...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $14.92M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.2¢ | 3.0¢ | $59.53K | 1.912M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1117600 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 490000 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| LDX (ASX) Chart |